Examination Report |
1 | TM-1 | 26 Nov 2010 |
10 | Hearing Notice | 12 Oct 2015 |
10 | Letter | 12 Oct 2015 |
11 | Hearing Notice | 12 Oct 2015 |
11 | Letter | 12 Oct 2015 |
12 | Letter | 13 Nov 2015 |
13 | Hearing Notice | 24 Oct 2016 |
14 | Journal Copy | 31 Oct 2016 |
15 | Order | 04 Nov 2016 |
16 | TM-5 | 23 Feb 2017 |
17 | Forwarding Letter for TM-5 | 02 May 2017 |
18 | Forwarding Letter for TM-6 | 24 Jul 2017 |
19 | Hearing Notice | 27 Jun 2018 |
2 | Additional Representation Sheet | 26 Nov 2010 |
20 | Order | 01 Oct 2018 |
21 | Annexure -1 under rule 46 | 27 Nov 2018 |
22 | Evidence Affidavit Under Rule 46 (TOP) | 27 Nov 2018 |
3 | Correspondence | 07 May 2012 |
4 | Reply to Exam Report (MIS-R) | 12 Oct 2012 |
5 | Affidavit | 07 Jul 2015 |
6 | Hearing Notice | 16 Jul 2015 |
6 | Note Sheet | 16 Jul 2015 |
7 | Hearing Notice | 16 Jul 2015 |
7 | Note Sheet | 16 Jul 2015 |
8 | Correspondence | 23 Jul 2015 |
9 | Authorization Letter | 10 Oct 2015 |
1 | Tribunal ABA Notice for : 2060018 | 4143494 | 24 Oct 2016 | |
2 | Opposition Notice | 4706456 | 18 Apr 2017 | |
3 | Opposition Counter Statement | 4947861 | 19 Jul 2017 |
Trademark was applied on 26 November 2010 with IP India.
Proprietor of Rejuv is MHS PHARMACEUTICALS.
Class(es) in which the trademark was applied to is 30.
Status of Rejuv is Opposed.
Application number alloted to the trademark is 2060018.
Trademark has been filed in the following category:
WORD